Bicycle Therapeutics Plc (BCYC)
4.10
-0.03
(-0.73%)
USD |
NASDAQ |
Sep 01, 16:00
4.10
0.00 (0.00%)
After-Hours: 20:00
Bicycle Therapeutics Cash from Investing (Quarterly) : -0.266M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.266M |
| March 31, 2026 | -0.7118M |
| December 31, 2025 | -0.5731M |
| September 30, 2025 | -0.6709M |
| June 30, 2025 | -0.5052M |
| March 31, 2025 | -0.6063M |
| December 31, 2024 | -0.3646M |
| September 30, 2024 | -0.4388M |
| June 30, 2024 | -0.4201M |
| March 31, 2024 | -0.012M |
| December 31, 2023 | -0.0496M |
| September 30, 2023 | -0.4997M |
| June 30, 2023 | -0.273M |
| March 31, 2023 | -2.118M |
| December 31, 2022 | -1.617M |
| September 30, 2022 | -2.892M |
| June 30, 2022 | -9.738M |
| Date | Value |
|---|---|
| March 31, 2022 | -4.729M |
| December 31, 2021 | -1.064M |
| September 30, 2021 | -0.1706M |
| June 30, 2021 | -0.1694M |
| March 31, 2021 | -0.6252M |
| December 31, 2020 | -0.4904M |
| September 30, 2020 | -0.0969M |
| June 30, 2020 | -0.3019M |
| March 31, 2020 | -0.3202M |
| December 31, 2019 | -0.3958M |
| September 30, 2019 | -0.282M |
| June 30, 2019 | -0.4612M |
| March 31, 2019 | -0.4224M |
| December 31, 2018 | -0.4077M |
| September 30, 2018 | -0.1273M |
| June 30, 2018 | -0.3827M |
| March 31, 2018 | -0.2658M |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Autolus Therapeutics Plc | 68.03M |
| Akari Therapeutics Plc | 0.00 |
| Biodexa Pharmaceuticals Plc | -- |
| DBV Technologies SA | -0.5998M |
| Cellectis SA | 18.75M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -49.69M |
| Cash from Financing (Quarterly) | -0.0501M |
| Free Cash Flow | -207.47M |
| Free Cash Flow Per Share (Quarterly) | -0.7157 |
| Free Cash Flow to Equity (Quarterly) | -49.23M |
| Free Cash Flow to Firm (Quarterly) | -49.92M |
| Free Cash Flow Yield | -72.77% |